These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26787638)

  • 1. Managing Subdural Bleeding Associated With Rivaroxaban: A Series of 3 Cases.
    Faust AC; Woodard S; Koehl JL; Mees W; Steinke D; Denetclaw TH
    J Pharm Pract; 2016 Jun; 29(3):257-62. PubMed ID: 26787638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Nonoperable Intracranial Bleeding Associated With Apixaban: A Series of 2 Cases.
    Faust AC; Tran DM; Lo C; Lai S; Sheperd L; Liu M; Denetclaw T
    J Pharm Pract; 2018 Feb; 31(1):107-111. PubMed ID: 29278991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation.
    Kauffmann S; Chabanne R; Coste A; Longeras F; Sinegre T; Schmidt J; Samama CM; Constantin JM; Lebreton A
    A A Case Rep; 2015 Jun; 4(11):151-4. PubMed ID: 26035221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Apixaban-Associated Gluteal Artery Extravasation Reversed With PCC3 Without FFP.
    Denetclaw TH; Tam J; Arias V; Kim R; Martin C
    J Pharm Pract; 2016 Aug; 29(4):427-30. PubMed ID: 26519251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor Xa Inhibitor-Related Intracranial Hemorrhage: Results From a Multicenter, Observational Cohort Receiving Prothrombin Complex Concentrates.
    Panos NG; Cook AM; John S; Jones GM;
    Circulation; 2020 May; 141(21):1681-1689. PubMed ID: 32264698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of coagulation markers and 4F-PCC-mediated reversal of rivaroxaban in a rabbit model of acute bleeding.
    Herzog E; Kaspereit F; Krege W; Mueller-Cohrs J; Doerr B; Niebl P; Dickneite G
    Thromb Res; 2015 Mar; 135(3):554-60. PubMed ID: 25619440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.
    Spiller HA; Mowry JB; Aleguas A; Griffith JR; Goetz R; Ryan ML; Bangh S; Klein-Schwartz W; Schaeffer S; Casavant MJ
    Ann Emerg Med; 2016 Feb; 67(2):189-95. PubMed ID: 26298448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery.
    Chic Acevedo C; Velasco F; Herrera C
    Future Cardiol; 2015 Sep; 11(5):525-9. PubMed ID: 26090568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation Test Interpretation in a Patient Taking Direct Oral Anticoagulant Therapy.
    Sholzberg M; Xu Y
    JAMA; 2018 Oct; 320(14):1485-1486. PubMed ID: 30242329
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracranial subdural hematomas with elevated rivaroxaban concentration and subsequently detected spinal subdural hematoma: A case report.
    Yamaguchi Y; Koga M; Matsuki T; Hino T; Yokota C; Toyoda K
    Thromb Res; 2016 Jul; 143():127-9. PubMed ID: 27240110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable outcome after a subdural hematoma treated with feiba in a 77-year-old patient treated by rivaroxaban.
    Maurice-Szamburski A; Graillon T; Bruder N
    J Neurosurg Anesthesiol; 2014 Apr; 26(2):183. PubMed ID: 24296541
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothrombin complex concentrate administration through intraosseous access for reversal of rivaroxaban.
    Means L; Gimbar RP
    Am J Emerg Med; 2016 Mar; 34(3):685.e1-2. PubMed ID: 26403851
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial.
    Piccini JP; Garg J; Patel MR; Lokhnygina Y; Goodman SG; Becker RC; Berkowitz SD; Breithardt G; Hacke W; Halperin JL; Hankey GJ; Nessel CC; Mahaffey KW; Singer DE; Califf RM; Fox KA;
    Eur Heart J; 2014 Jul; 35(28):1873-80. PubMed ID: 24658769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated prothrombin complex concentrate for dabigatran-associated bleeding.
    Schulman S; Ritchie B; Goy JK; Nahirniak S; Almutawa M; Ghanny S
    Br J Haematol; 2014 Jan; 164(2):308-10. PubMed ID: 24383848
    [No Abstract]   [Full Text] [Related]  

  • 15. Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors.
    Grandhi R; Newman WC; Zhang X; Harrison G; Moran C; Okonkwo DO; Ducruet AF
    World Neurosurg; 2015 Dec; 84(6):1956-61. PubMed ID: 26341438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
    Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
    Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of rivaroxaban using Prothromplex Total, a 4-factor prothrombin complex.
    Kaur H; Yeang SH; See E; Grant D; Tan CW; Wong WH; Tan D; Ng HJ; Lee LH
    Thromb Res; 2017 Aug; 156():117-118. PubMed ID: 28624719
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity.
    Rinehart DR; Lockhart NR; Hamilton LA; Langdon JR; Rowe AS
    Crit Care Med; 2015 Jun; 43(6):e203-7. PubMed ID: 25738855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemostatic therapy in experimental intracerebral hemorrhage associated with rivaroxaban.
    Zhou W; Zorn M; Nawroth P; Bütehorn U; Perzborn E; Heitmeier S; Veltkamp R
    Stroke; 2013 Mar; 44(3):771-8. PubMed ID: 23339956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivaroxaban-Induced Gastrointestinal Bleeding Presenting as Acute Colon Obstruction.
    Cohen M; Nevo H; Hershko D; Becker A
    Pharmacology; 2017; 99(3-4):124-127. PubMed ID: 27988509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.